# Interparfums Inc: financial statements, quarterly

IPAR · Nasdaq · CIK 822663 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ipar.md) · [Financials](/companies/ipar/financials.md) · [Filings](/companies/ipar/filings.md) · [Insiders](/companies/ipar/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ipar/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [368](/filings/0001753926-24-001818.md) | [329 d](/filings/0001753926-24-000405.md) | [324](/filings/0001753926-25-000738.md) | [342](/filings/0001753926-25-001236.md) | [425](/filings/0001753926-25-001703.md) | [362 d](/filings/0001753926-26-000464.md) | [339](/filings/0001753926-26-000771.md) | [334](/filings/0001753926-26-001317.md) | [430](/filings/0001753926-25-001703.md) | [386 d](/filings/0001753926-26-000464.md) | [345](/filings/0001753926-26-000771.md) | [341](/filings/0001753926-26-001317.md) |
| Cost of revenue | $m | [133](/filings/0001753926-24-001818.md) | [116 d](/filings/0001753926-26-000464.md) | [122](/filings/0001753926-25-000738.md) | [121](/filings/0001753926-25-001236.md) | [153](/filings/0001753926-25-001703.md) | [128 d](/filings/0001753926-26-000464.md) | [123](/filings/0001753926-26-000771.md) | [113](/filings/0001753926-26-001317.md) | [157](/filings/0001753926-25-001703.md) | [149 d](/filings/0001753926-26-000464.md) | [120](/filings/0001753926-26-000771.md) | [118](/filings/0001753926-26-001317.md) |
| Gross profit | $m | [235](/filings/0001753926-24-001818.md) | [213 d](/filings/0001753926-26-000464.md) | [202](/filings/0001753926-25-000738.md) | [221](/filings/0001753926-25-001236.md) | [271](/filings/0001753926-25-001703.md) | [233 d](/filings/0001753926-26-000464.md) | [216](/filings/0001753926-26-000771.md) | [221](/filings/0001753926-26-001317.md) | [273](/filings/0001753926-25-001703.md) | [237 d](/filings/0001753926-26-000464.md) | [225](/filings/0001753926-26-000771.md) | [224](/filings/0001753926-26-001317.md) |
| Selling, general and administrative | $m | [148](/filings/0001753926-24-001818.md) | [194 d](/filings/0001753926-26-000464.md) | [134](/filings/0001753926-25-000738.md) | [156](/filings/0001753926-25-001236.md) | [165](/filings/0001753926-25-001703.md) | [193 d](/filings/0001753926-26-000464.md) | [141](/filings/0001753926-26-000771.md) | [162](/filings/0001753926-26-001317.md) | [164](/filings/0001753926-25-001703.md) | [210 d](/filings/0001753926-26-000464.md) | [151](/filings/0001753926-26-000771.md) | [175](/filings/0001753926-26-001317.md) |
| Operating income | $m | [87.2](/filings/0001753926-24-001818.md) | [18.9 d](/filings/0001753926-26-000464.md) | [68.0](/filings/0001753926-25-000738.md) | [64.8](/filings/0001753926-25-001236.md) | [106](/filings/0001753926-25-001703.md) | [36.0 d](/filings/0001753926-26-000464.md) | [75.1](/filings/0001753926-26-000771.md) | [59.2](/filings/0001753926-26-001317.md) | [109](/filings/0001753926-25-001703.md) | [27.5 d](/filings/0001753926-26-000464.md) | [74.1](/filings/0001753926-26-000771.md) | [48.9](/filings/0001753926-26-001317.md) |
| Interest expense | $m | [2.4](/filings/0001753926-23-001460.md) | [4.2 d](/filings/0001753926-24-000405.md) | [1.8](/filings/0001753926-24-000926.md) | [1.9](/filings/0001753926-25-001236.md) | [2.0](/filings/0001753926-25-001703.md) | [2.1 d](/filings/0001753926-26-000464.md) | [1.5](/filings/0001753926-26-000771.md) | [1.8](/filings/0001753926-26-001317.md) | [2.3](/filings/0001753926-25-001703.md) | [1.6 d](/filings/0001753926-26-000464.md) | [1.4](/filings/0001753926-26-000771.md) | [1.5](/filings/0001753926-26-001317.md) |
| Income tax | $m | [20.5](/filings/0001753926-24-001818.md) | [6.7 d](/filings/0001753926-26-000464.md) | [16.8](/filings/0001753926-25-000738.md) | [14.7](/filings/0001753926-25-001236.md) | [23.6](/filings/0001753926-25-001703.md) | [10.0 d](/filings/0001753926-26-000464.md) | [18.0](/filings/0001753926-26-000771.md) | [12.9](/filings/0001753926-26-001317.md) | [24.3](/filings/0001753926-25-001703.md) | [8.0 d](/filings/0001753926-26-000464.md) | [18.5](/filings/0001753926-26-000771.md) | [11.4](/filings/0001753926-26-001317.md) |
| Net income | $m | [53.2](/filings/0001753926-24-001818.md) | [10.4 d](/filings/0001753926-26-000464.md) | [41.0](/filings/0001753926-25-000738.md) | [36.8](/filings/0001753926-25-001236.md) | [62.3](/filings/0001753926-25-001703.md) | [24.2 d](/filings/0001753926-26-000464.md) | [42.5](/filings/0001753926-26-000771.md) | [32.0](/filings/0001753926-26-001317.md) | [65.8](/filings/0001753926-25-001703.md) | [28.1 d](/filings/0001753926-26-000464.md) | [43.4](/filings/0001753926-26-000771.md) | [30.5](/filings/0001753926-26-001317.md) |
| Diluted EPS | $ per share | [1.66](/filings/0001753926-24-001818.md) | not reported | [1.27](/filings/0001753926-25-000738.md) | [1.14](/filings/0001753926-25-001236.md) | [1.93](/filings/0001753926-25-001703.md) | not reported | [1.32](/filings/0001753926-26-000771.md) | [0.99](/filings/0001753926-26-001317.md) | [2.05](/filings/0001753926-25-001703.md) | not reported | [1.35](/filings/0001753926-26-000771.md) | [0.95](/filings/0001753926-26-001317.md) |
| Basic EPS | $ per share | [1.66](/filings/0001753926-24-001818.md) | not reported | [1.28](/filings/0001753926-25-000738.md) | [1.15](/filings/0001753926-25-001236.md) | [1.94](/filings/0001753926-25-001703.md) | not reported | [1.32](/filings/0001753926-26-000771.md) | [1.00](/filings/0001753926-26-001317.md) | [2.05](/filings/0001753926-25-001703.md) | not reported | [1.35](/filings/0001753926-26-000771.md) | [0.95](/filings/0001753926-26-001317.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [79.8](/filings/0001753926-23-001460.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current assets | $m | [877](/filings/0001753926-23-001460.md) | [839](/filings/0001753926-25-000424.md) | [833](/filings/0001753926-24-000926.md) | [857](/filings/0001753926-24-001363.md) | [956](/filings/0001753926-24-001818.md) | [926](/filings/0001753926-26-000464.md) | [911](/filings/0001753926-25-000738.md) | [987](/filings/0001753926-25-001236.md) | [991](/filings/0001753926-25-001703.md) | [1,027](/filings/0001753926-26-001317.md) | [998](/filings/0001753926-26-000771.md) | [951](/filings/0001753926-26-001317.md) |
| Total assets | $m | [1,394](/filings/0001753926-23-001460.md) | [1,369](/filings/0001753926-26-000464.md) | [1,349](/filings/0001753926-24-000926.md) | [1,364](/filings/0001753926-24-001363.md) | [1,481](/filings/0001753926-24-001818.md) | [1,411](/filings/0001753926-26-000464.md) | [1,441](/filings/0001753926-25-000738.md) | [1,562](/filings/0001753926-25-001236.md) | [1,565](/filings/0001753926-25-001703.md) | [1,585](/filings/0001753926-26-001317.md) | [1,543](/filings/0001753926-26-000771.md) | [1,490](/filings/0001753926-26-001317.md) |
| Current liabilities | $m | [363](/filings/0001753926-23-001460.md) | [325](/filings/0001753926-25-000424.md) | [302](/filings/0001753926-24-000926.md) | [332](/filings/0001753926-24-001363.md) | [340](/filings/0001753926-24-001818.md) | [332](/filings/0001753926-26-000464.md) | [306](/filings/0001753926-25-000738.md) | [333](/filings/0001753926-25-001236.md) | [303](/filings/0001753926-25-001703.md) | [344](/filings/0001753926-26-001317.md) | [306](/filings/0001753926-26-000771.md) | [287](/filings/0001753926-26-001317.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [481](/filings/0001753926-26-001317.md) | not reported | [399](/filings/0001753926-26-001317.md) |
| Long-term debt | $m | [129](/filings/0001753926-23-001460.md) | [128](/filings/0001753926-25-000424.md) | [116](/filings/0001753926-24-000926.md) | [108](/filings/0001753926-24-001363.md) | [135](/filings/0001753926-24-001818.md) | [116](/filings/0001753926-26-000464.md) | [107](/filings/0001753926-25-000738.md) | [153](/filings/0001753926-25-001236.md) | [140](/filings/0001753926-25-001703.md) | [121](/filings/0001753926-26-001317.md) | [107](/filings/0001753926-26-000771.md) | [96.5](/filings/0001753926-26-001317.md) |
| Current portion of debt | $m | [41.8](/filings/0001753926-23-001460.md) | [29.6](/filings/0001753926-25-000424.md) | [29.0](/filings/0001753926-24-000926.md) | [28.7](/filings/0001753926-24-001363.md) | [44.5](/filings/0001753926-24-001818.md) | [41.6](/filings/0001753926-26-000464.md) | [43.4](/filings/0001753926-25-000738.md) | [56.7](/filings/0001753926-25-001236.md) | [56.9](/filings/0001753926-25-001703.md) | [54.8](/filings/0001753926-26-001317.md) | [50.2](/filings/0001753926-26-000771.md) | [46.3](/filings/0001753926-26-001317.md) |
| Short-term borrowings | $m | not reported | [4.4](/filings/0001753926-25-000424.md) | not reported | not reported | not reported | [8.3](/filings/0001753926-26-000464.md) | not reported | not reported | not reported | [9.4](/filings/0001753926-26-000464.md) | not reported | not reported |
| Shareholders' equity | $m | [690](/filings/0001753926-23-001460.md) | [699](/filings/0001753926-25-000424.md) | [708](/filings/0001753926-24-000926.md) | [717](/filings/0001753926-24-001363.md) | [778](/filings/0001753926-24-001818.md) | [745](/filings/0001753926-26-000464.md) | [789](/filings/0001753926-25-000738.md) | [839](/filings/0001753926-25-001236.md) | [871](/filings/0001753926-25-001703.md) | [881](/filings/0001753926-26-001317.md) | [882](/filings/0001753926-26-000771.md) | [870](/filings/0001753926-26-001317.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [17.5 d](/filings/0001753926-24-001818.md) | [81.5 d](/filings/0001753926-26-000464.md) | [(52.0)](/filings/0001753926-25-000738.md) | [25.5 d](/filings/0001753926-25-001236.md) | [76.1 d](/filings/0001753926-25-001703.md) | [138 d](/filings/0001753926-26-000464.md) | [(7.4)](/filings/0001753926-26-000771.md) | [11.9 d](/filings/0001753926-26-001317.md) | [63.9 d](/filings/0001753926-25-001703.md) | [147 d](/filings/0001753926-26-000464.md) | [0.1](/filings/0001753926-26-000771.md) | [45.6 d](/filings/0001753926-26-001317.md) |
| Capital expenditure | $m | [1.4 d](/filings/0001753926-24-001818.md) | [1.9 d](/filings/0001753926-26-000464.md) | [1.1](/filings/0001753926-25-000738.md) | [1.1 d](/filings/0001753926-25-001236.md) | [0.8 d](/filings/0001753926-25-001703.md) | [1.9 d](/filings/0001753926-26-000464.md) | [1.4](/filings/0001753926-26-000771.md) | [15.2 d](/filings/0001753926-26-001317.md) | [6.2 d](/filings/0001753926-25-001703.md) | [1.5 d](/filings/0001753926-26-000464.md) | [1.4](/filings/0001753926-26-000771.md) | [1.0 d](/filings/0001753926-26-001317.md) |
| Dividends paid | $m | [20.0 d](/filings/0001753926-24-001818.md) | [20.0 d](/filings/0001753926-26-000464.md) | [24.0](/filings/0001753926-25-000738.md) | [23.9 d](/filings/0001753926-25-001236.md) | [24.0 d](/filings/0001753926-25-001703.md) | [24.0 d](/filings/0001753926-26-000464.md) | [25.7](/filings/0001753926-26-000771.md) | [25.7 d](/filings/0001753926-26-001317.md) | [25.7 d](/filings/0001753926-25-001703.md) | [25.6 d](/filings/0001753926-26-000464.md) | [25.6](/filings/0001753926-26-000771.md) | [25.6 d](/filings/0001753926-26-001317.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [0.0](/filings/0001753926-23-001460.md) | [0.0](/filings/0001753926-24-000926.md) | [0.0](/filings/0001753926-24-001363.md) | [0.0](/filings/0001753926-24-001818.md) | [32.3](/filings/0001753926-25-000738.md) | [32.3](/filings/0001753926-25-001236.md) | [32.3](/filings/0001753926-25-001703.md) | [32.2](/filings/0001753926-26-000771.md) | [32.1](/filings/0001753926-26-001317.md) | [32.1](/filings/0001753926-25-001703.md) | [32.0](/filings/0001753926-26-000771.md) | [32.0](/filings/0001753926-26-001317.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 32,025,781 at 2026-08-04, from the cover of the [10-Q filed 2026-08-04](/filings/0001753926-26-001317.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.